These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14013915)

  • 1. [Bullous lung disease caused by Pseudomonas aeruginosa (Bacillus pyocyaneus)].
    BORENZSTEIN I; BARRERA HERNANDEZ E; BERENGUER E; CAMPS R
    Sem Med; 1962 Sep; 121():1164-8. PubMed ID: 14013915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sepsis caused by Bacillus pyocyaneus in a small child].
    Zujović J; Josipović Z; Milosević V; Petrović Lj
    Srp Arh Celok Lek; 1969 May; 97(5):618-20. PubMed ID: 4985275
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary Bacillus pyocyaneus infection in an adult with recovery.
    BIFULCO E
    N Y State J Med; 1949 May; 49(10):1195. PubMed ID: 18135936
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of Pseudomonas pyocyaneus septicaemia with pulmonary complications.
    Sambandam S; Ahmed SA; Paul J; Kalyani VR
    J Assoc Physicians India; 1977 May; 25(5):371-3. PubMed ID: 914771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Septicemia due to Pseudomonas aeruginosa (Bacillus pyocyaneus) with meningitis and multiple osteoarticular localizations. Treatment by colimycin. Cure].
    CATHALA J; MARTIN G
    Nourrisson; 1960; 48():41-8. PubMed ID: 13691568
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulmonary pathology of the infant caused by Pseudomonas aeruginosa].
    BURLINA A
    Riv Anat Patol Oncol; 1962 Dec; 22():1095-123. PubMed ID: 14017087
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease.
    Sorichter S; Baumann U; Baumgart A; Walterspacher S; von Specht BU
    Vaccine; 2009 May; 27(21):2755-9. PubMed ID: 19366571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of infections caused by Bacillus pyocyaneus in infants].
    SITBON C
    Nourrisson; 1957; 45(1):37-44. PubMed ID: 13419163
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenicity of Pseudomonas aeruginosa (Bacillus pyocyaneus); experimental studies and report of a case.
    HUBBARD JD; KING H; BEAMER PR
    Am J Clin Pathol; 1957 Sep; 28(3):243-57. PubMed ID: 13458152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenic role of Bacillus pyocyaneus in infections in children].
    LINDENBAUM I
    Pediatr Pol; 1952 Sep; 27(9):1041-56. PubMed ID: 13003374
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cerebrospinal meningitis caused by Bacillus pyocyaneus].
    NIZNIKOWSKA-MARKS MJ; OKNINSKA A
    Pediatr Pol; 1960 Nov; 35():1331-7. PubMed ID: 13729341
    [No Abstract]   [Full Text] [Related]  

  • 12. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
    Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
    J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.
    Wu H; Song Z; Hentzer M; Andersen JB; Molin S; Givskov M; Høiby N
    J Antimicrob Chemother; 2004 Jun; 53(6):1054-61. PubMed ID: 15117922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apropos of a case of Bacillus pyocyaneus meningitis].
    NIQUET G; LEKIEFFRE J; DHALLUIN R; ROUSSEL C
    Lille Med; 1962 Apr; 7():327-31. PubMed ID: 14479927
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of lung epithelial functions by Pseudomonas aeruginosa.
    Lau GW; Hassett DJ; Britigan BE
    Trends Microbiol; 2005 Aug; 13(8):389-97. PubMed ID: 15951179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
    Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.
    Ramsey DM; Wozniak DJ
    Mol Microbiol; 2005 Apr; 56(2):309-22. PubMed ID: 15813726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1.
    Grassmé H; Jin J; Wilker B; von Kürthy G; Wick W; Weller M; Möröy T; Gulbins E
    Cell Microbiol; 2006 Jul; 8(7):1096-105. PubMed ID: 16819963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
    J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory effect of augmented nitric oxide production in chronic lung infection.
    Hopkins N; Gunning Y; O'Croinin DF; Laffey JG; McLoughlin P
    J Pathol; 2006 Jun; 209(2):198-205. PubMed ID: 16538611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.